Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Can persistent infections contribute to neural autoimmunity through molecular mimicry and cross-reactive antibodies?

Persistent infections and post-infectious immune responses can contribute to neural autoimmunity through molecular mimicry and cross-reactive antibodies.

PlausibleAugust 26, 202627 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Persistent microbial immune stimulation from Borrelia, Epstein-Barr virus, cytomegalovirus, Mycoplasma pneumoniae, and Streptococcus A can contribute to neural autoimmunity through molecular mimicry and cross-reactive antibodies.

laying out figure…
1 of 11 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says Borrelia, EBV, CMV, Mycoplasma pneumoniae, and group A Streptococcus may all be involved in immune stimulation that can affect neural targets. The mechanism framing emphasizes molecular mimicry, where microbial antigens resemble neural structures and provoke cross-reactive antibodies. The evidence is strongest for EBV and for molecular mimicry as a general mechanism, while the other organisms are supported more variably.

Verified conclusion

Persistent infections and post-infectious immune responses can create conditions in which microbial antigens resemble neural structures, but the strength of evidence differs substantially among the organisms named and by neurologic syndrome.

Clinical and immunologic evidence

  • EBV has the strongest support as a persistent antigenic and immune-modulating exposure: lifelong latency in memory B cells and intermittent reactivation can sustain B-cell activation and type-I-interferon signaling. In a prospective military cohort, EBV infection preceded MS in nearly all initially seronegative cases and was associated with an approximately 32-fold increase in subsequent MS risk.
  • CMV plausibly produces persistent T-cell–centered stimulation, including expansion of CMV-specific CD8+ effector/EMRA cells (“memory inflation”), a particularly relevant immune-aging phenotype in older adults. CMV reactivation has also been associated with increased IFN-α and TNF-α.
  • After treated Borrelia infection, elevated CCL19 at one month predicted persistent symptoms at 6–12 months, supporting sustained immune dysregulation; this does not establish viable ongoing infection.
  • Mycoplasma pneumoniae and group A Streptococcus are most convincingly linked to post-infectious, rather than demonstrably persistent, immune activation.

Molecular mimicry and neural targets

  • Molecular mimicry and cross-reactive antibodies are established contributors to selected neurologic diseases. The canonical example is Campylobacter-associated Guillain–Barré syndrome, where antibodies to bacterial lipooligosaccharides bind neural gangliosides.
  • EBNA1-reactive antibodies can cross-recognize CNS proteins including GlialCAM, ANO2, and CRYAB. CMV-associated GBS includes anti-GM2 antibodies recognizing epitopes on CMV-infected cells.
  • M. pneumoniae neurologic cohorts show anti-galactocerebroside antibodies: 23/46 cases in one multicenter cohort. In Sydenham chorea, GAS-directed antibodies recognize both GlcNAc and neuronal lysoganglioside GM1. Borrelia flagellin antibodies cross-react with axonal HSP60 in vitro.

Bottom line

  • Persistent microbial immune stimulation is a biologically credible contributor—not a universal or sufficient cause—of neural autoimmunity. EBV has the strongest persistence-related case; CMV and Borrelia are plausible; and Mycoplasma and GAS are best supported as triggers of post-infectious molecular mimicry in susceptible individuals.

References

  1. Persistent inflammation linked to development of Post- ... — hopkinslyme.org ↗
  2. Longitudinal Transcriptome Analysis Reveals a Sustained ... - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  3. Post-treatment Lyme Disease as a Model for Persistent ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  4. Epstein-Barr virus and multiple sclerosis — science.org ↗
  5. The enigmatic links between Epstein-Barr virus infection and ... — pmc.ncbi.nlm.nih.gov ↗
  6. Cytomegalovirus-specific T-cells are associated with immune ... — nature.com ↗
  7. T-cell immunity against cytomegalovirus in HIV infection and aging — pmc.ncbi.nlm.nih.gov ↗
  8. Cytomegalovirus Infection and Memory T Cell Inflation - PMC — pmc.ncbi.nlm.nih.gov ↗
  9. Effect of Cytomegalovirus Reactivation on Inflammatory Status and ... — pmc.ncbi.nlm.nih.gov ↗
  10. Post-infectious encephalitis with anti-galactocerebroside antibody ... — pubmed.ncbi.nlm.nih.gov ↗
  11. Characterization of the neurological diseases associated ... - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  12. Mycoplasma pneumoniae–associated Central Nervous System ... — academic.oup.com ↗
  13. Pathogenesis and Treatment of Neurologic Diseases Associated ... — pmc.ncbi.nlm.nih.gov ↗
  14. Diagnostic Approach to Pediatric Autoimmune ... — frontiersin.org ↗
  15. PANDAS Syndrome: A Narrative Review of the Diagnostic ... - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  16. Guillain-Barré syndrome: expanding the concept of molecular ... — pmc.ncbi.nlm.nih.gov ↗
  17. Molecular mimicry: cross-reactive antibodies from patients ... — pubmed.ncbi.nlm.nih.gov ↗
  18. Guillain-Barré syndrome: expanding the concept of molecular ... — pubmed.ncbi.nlm.nih.gov ↗
  19. Ganglioside mimicry as a cause of Guillain-Barré syndrome — pubmed.ncbi.nlm.nih.gov ↗
  20. Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive ... — pmc.ncbi.nlm.nih.gov ↗
  21. Streptococcal mimicry and antibody-mediated cell ... — pubmed.ncbi.nlm.nih.gov ↗
  22. Ganglioside Molecular Mimicry and Its Pathological Roles in Guillain-Barré Syndrome and Related Diseases | Infection and Immunity — journals.asm.org ↗
  23. Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk | PNAS — pnas.org ↗
  24. Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis — science.org ↗
  25. Clonally Expanded B Cells in Multiple Sclerosis Bind EBV ... — pmc.ncbi.nlm.nih.gov ↗
  26. Cross-reactive antibodies against GM2 and CMV-infected ... — pubmed.ncbi.nlm.nih.gov ↗
  27. A monoclonal antibody to Borrelia burgdorferi flagellin modifies neuroblastoma cell neuritogenesis in vitro: a possible role for autoimmunity in the neuropathy of Lyme disease — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesDoes low-normal vitamin D weaken immune resilience?→Plausible11 sourcesCan low zinc and low vitamin D constrain immune pathways while an optimal hs-CRP does not support active systemic inflammation?→